Thursday, December 13, 2012

Adherence to hepatitis C treatment: unravelling the complexities

Adherence to hepatitis C treatment: unravelling the complexities

Rob Camp, Keith Alcorn
Published: 13 December 2012
 
Successful adherence to hepatitis C treatment may require physicians and care teams to address a wide range of factors, according to research from the United States and Germany presented at The Liver Meeting 2012, the 63rd annual meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston last month.

Hepatitis C treatment presents a number of adherence challenges that are distinct from other disease areas, due to the use of pegylated interferon, which causes both physical and psychological side-effects that affect numerous areas of a patient’s life during a treatment course that may last up to 48 weeks, and which may be undergone several times if the first course is unsuccessful.

Continue Reading @ aidsmap.com  

No comments:

Post a Comment